Publication | Open Access
Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19
34
Citations
31
References
2021
Year
In our cohort of kidney transplant recipients, remdesivir was well tolerated and safe in renal and hepatic toxicity, but randomized trials are needed to assess its efficacy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1